Walgreens back in the long-term care market, sort of

Share this article:

With more vendors targeting the hospice market, two drug giants appear ready to face off. Walgreens left the institutional-pharmacy business in 2010, of which hospice pharmacy is a part, in a deal with Omnicare. Walgreens traded the unit for Omnicare's home-infusion business. Since then, Omnicare has been the market leader for hospice drugs. So why the strategy change for Walgreens? One reason is that hospice remains a largely fragmented market. It also isn't dominated by pharmacy benefit managers. Walgreens sees these factors as key advantages as it attempts to resettle in this part the long-term care sector. By some estimates, the institutional pharmacy market — including skilled care, hospice and assisted living — is currently worth about $14 billion a year.

Share this article:
close

Next Article in Products

More in Products

Last day to enter McKnight's Tech Awards

Today is the final day to submit entries into the third annual McKnight's Excellence in Technology Awards.

AliMed offers three new fall management products

AliMed offers three new fall management products

AliMed is now offering the AliMed CordLess® Sensor Alarm and the AliMed Worry-Free Fall Alarm to help reduce the risk of accidental falls, and the HipShield® X-tra to help prevent ...

Diamond Wipes creates new wipes

Diamond Wipes creates new wipes

Diamond Wipes has announced an updated version of its Handyclean™ cleaning and sanitizing wipes.